Souhaitez-vous accéder aux communiqués récents ?

MENLO PARK, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing...

Opportunistic refinancing meaningfully reduces cost of capital with 8.25% fixed interest rate and extends amortization period to Q1 2030 $200 million funded at closing to refinance the existing $125...

Acquisition includes HS235, a potentially best-in-class activin signalling inhibitor in clinical development for treatment of cardiopulmonary diseasesHS235 offers potential to treat pulmonary...

ZUG, Switzerland, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Ms. Kazem brings extensive and global expertise in corporate governance and securities law, drawing on a distinguished track record as external...

Ms. Kazem brings extensive and global expertise in corporate governance and securities law, drawing on a distinguished track record as external legal counsel to leading life sciences companiesChief...

SAN DIEGO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Primmune Therapeutics, Inc., a biotech company harnessing the power of the innate immune system, today announced the appointment of Andrew Sharabi, M.D.,...

All-stock transaction brings Tempest a portfolio of next-generation CAR-T assets, including TPST-2003, a clinical-stage dual-targeting CD-19/BCMA CAR-T with strategic partner-funded BLA filing in...

Acquired Business Expected to Generate $300 Million in Revenue in 12 Months Post-Close, with 70% Gross MarginHigh-Growth AI Datacenter-Comms Represents ~75% of Acquired Revenue Accelerates SiTime’s...

Acquisition marks the sixth purchase of an authorised VMware partner for 11:11 Systems, now one of the largest private VMware Cloud Service Provider...

Acquisition marks the sixth purchase of an authorised VMware partner for 11:11 Systems, now one of the largest private VMware Cloud Service Provider partners...